Skye Bioscience, Inc. announced that on February 14, 2023, Bobby Rai resigned as a member of the Board of Directors of the company and the Nominating and Corporate Governance Committee of the Board. Mr. Rai's resignation as a director was to focus on other commitments and is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.61 USD | -0.34% | -3.73% | +326.84% |
10/05 | Skye Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
23/04 | Skye Bioscience, Inc.(NasdaqGM:SKYE) added to NASDAQ Transportation Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+326.84% | 326M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- EMBI Stock
- News Skye Bioscience, Inc.
- Skye Bioscience, Inc. Announces Resignation of Bobby Rai as a Member of the Board of Directors and the Nominating and Corporate Governance Committee of the Board